key articles
Obesity and its role in prostate cancer screening
Monday, 23 January 2012- Researchers in Family and Community Medicine at Thomas Jefferson University in the US recently found that obesity was linked to higher rates of prostate cancer (PCa) screening across all races/ethnic...
Edited by: JV
Erectile and urinary functions after nerve-sparing radical prostatectomy
Monday, 16 January 2012- The association between baseline functional status and urinary continence recovery after radical prostatectomy remains controversial. G. Gandaglia and colleagues tested the hypothesis that baseline...
Edited by: JV
No evidence of mortality benefit for mass screening in PCa, says PCLO study
Tuesday, 10 January 2012- The prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was undertaken to determine whether there is a reduction in prostate cancer mortality from...
Edited by: JV
Focal salvage therapy for localised PCa recurrence after external beam radiotherapy
Monday, 9 January 2012- H. S. Ahmed and colleagues conducted a study to evaluate the safety, feasibility, side-effect profile, and proof of concept for focal salvage therapy using high-intensity focused ultrasound (HIFU). They...
Edited by: JV
Conventional vs hypofractionated high-dose intensity-modulated radiotherapy for PCa
Wednesday, 4 January 2012- Prostate cancer might have high radiation-fraction sensitivity, implying a therapeutic advantage of hypofractionated treatment.
D. Dearnaley and colleagues conducted a pre-planned preliminary safety...
Edited by: JV
Novel Vitamin D analog ZK191784 inhibits prostate cancer cell invasion
Tuesday, 3 January 2012- Low serum levels of 1,25(OH)2D3 (1,25D), have been associated with aggressive biologic behavior of prostate cancer (PCa).
In their study, the results of which were published in the journal Anticancer...
Edited by: JV
Emerging novel therapies for advanced prostate cancer
Tuesday, 27 December 2011- S. Osanto and H. Van Poppel published a review in an online issue of the journal Therapeutic Advances in Urology examining the development and efficacy of novel treatment options for...
Edited by: JV
Sipuleucel-T for castration-resistant prostate cancer
Friday, 23 December 2011- Sipuleucel-T is known to be very well tolerated and to prolong overall survival, but not progression-free survival, measured according to prostate-specific antigen variations and radiographic...
Edited by: JV
Statin use and fatal prostate cancer: a matched case-control study
Tuesday, 20 December 2011- Statins are some of the most commonly prescribed medications in medical practice, and prostate cancer is the most common malignancy among men.
Although there has been no consistent evidence that...
Edited by: JV
HOPE fixation technique - a promising alternative to common PCa biobanking approaches
Tuesday, 13 December 2011- The availability of well-annotated prostate tissue samples through biobanks is key for research. Whereas fresh-frozen tissue is well suited for a broad spectrum of molecular analyses, its storage and...
Edited by: JV
